Recently, Song et al. reported a novel LC3b–EGF–EGFR regulation in NANOG+ tumor cells and demonstrated that LC3b contributed to the secretion of EGF, thereby activating EGFR signaling [30]. Here, MAP1LC3B is linked to neoplasm.